We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OPRA:NASDAQOpera Limited Analysis

Data as of 2026-06-13 - not real-time

$18.18

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Opera Limited (OPRA) is trading at $18.18, comfortably above its 20‑day SMA (18.03) and 50‑day SMA (17.46), indicating a short‑term bullish bias, while still below the 200‑day SMA (15.63) that suggests ample upside potential. The RSI sits at 53, signaling neutral momentum, and the MACD histogram is negative, hinting at a near‑term pullback risk. The stock’s beta of 1.51 and 30‑day volatility of 31.8% point to a high‑risk profile, yet the recent Extreme Greed market sentiment (fear‑greed index 89.86) may be inflating short‑term demand. Fundamentally, OPRA trades at a forward PE of 10.4 versus an industry average of 16.98, and the DCF‑derived fair value of $50.08 implies a 44.6% upside. A dividend yield of 4.4% with a payout ratio around 63%, supported by solid operating cash flow and a modest debt load, underscores dividend sustainability. The recent announcement of a $0.40 cash dividend reinforces the commitment to shareholder returns. Overall, the combination of undervaluation, strong cash generation, and a strategic focus on AI‑enhanced browsers suggests a compelling long‑term case, while the technical setup warrants cautious positioning in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above 20‑day and 50‑day SMAs indicating short‑term strength
  • Negative MACD histogram suggesting possible near‑term pullback
  • Stable volume and support level at $16.73 providing downside protection

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value $50.08 implies ~45% upside
  • Forward PE of 10.4 well below industry average
  • Attractive 4.4% dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strong revenue growth (23% YoY) and healthy operating margins
  • Strategic AI and Web3 initiatives expanding future growth avenues
  • Robust cash generation and low debt supporting long‑term financial health

Key Metrics & Analysis

Financial Health

Revenue Growth23.20%
Profit Margin17.71%
P/E Ratio14.4
ROE11.97%
ROA5.76%
Debt/Equity0.90
P/B Ratio1.7
Op. Cash Flow$143.9M
Free Cash Flow$128.4M
Industry P/E17.0

Technical Analysis

TrendBullish
RSI53.1
Support$16.73
Resistance$19.38
MA 20$18.03
MA 50$17.46
MA 200$15.63
MACDBearish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value$50.08
Target Price$26.29
Upside/Downside44.59%
GradeUndervalued
TypeBlend
Dividend Yield4.40%

Risk Assessment

Beta1.51
Volatility31.84%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.